Tag: Asterias Biotherapeutics

January 4, 2017

The Life Sciences Report Announces 19 Companies Selected for the 2017 Small-Cap Biotech Watchlist

The 2017 Life Sciences Report Biotech Watchlist includes nineteen small-cap biotech companies selected by top analysts in the field.
October 13, 2016

How 3 Top Stem Cell Research Companies Are Changing Biotech Investing

What’s the state of the market now, who are today’s top stem cell research companies and why might stem cell...
February 29, 2016

Asterias Biotherapeutics Gets New President and CEO

Asterias Biotherapeutics Inc. (NYSEMKT:AST) announced that Stephen L. Cartt has been appointed president and CEO of the company, and has...
February 17, 2016

Asterias Biotherapeutics Announces Intention to Distribute 3.15 Million Warrants

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) simplified its capital structure through the previously announced Asset Swap with BioTime, Inc. In conjunction with...
February 4, 2016

Asterias Biotherapeutics Granted Orphan Drug Designation for AST-OPC1 for the Treatment of Acute Spinal Cord Injury

Asterias Biotherapeutics, Inc. (NYSE MKT:AST) has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) for...